Introduction
Over the past decades epilepsy surgery has become an important treatment option for medically refractory epilepsy. 1 However, up to 30% of referred patients who undergo pre-surgical evaluation ultimately are not considered eligible for epilepsy surgery. Lack of clear focus localization is the main reason for not offering surgery. 2 As the diagnostic arsenal and treatment possibilities expand, the perspectives for refractory epilepsy patient change.
Recent developments in anatomical and functional neuroimaging and epileptic source localization may lead to improved focus localization, which may offer new surgical vistas. Minor structural abnormalities may not be visible with conventional low field-strength MRI can underlie epileptogenic areas. Higher resolution MRI or co-registration of functional (MEG, EEG, PET and SPECT) source localization with anatomical MRI may improve detection in these cases. In a recent study, in 65% of patients with prior normal 1.5 T MRI, 3 T phased array MRI Seizure (2008) Summary The pre-surgical work-up of patients with medically refractory epilepsy changes with the availability of new diagnostic procedures. New diagnostic investigations may also open up prospects for patients rejected in the past. A cohort of 71 Dutch patients rejected for epilepsy surgery 0.5-5 years earlier were approached to evaluate their willingness to undergo novel techniques. 64 (90%) responded to a questionnaire evaluating social and medical status, quality of life (QoL) and motivation to be reconsidered for epilepsy surgery. Four patients (6%) did not have seizures during the last 6 months. 56 patients (88%) were highly motivated to undergo new diagnostic procedures. Inability to localize the seizure focus had been the reason for rejection in 70% of these. We conclude that most patients once rejected for epilepsy surgery would like to benefit from novel techniques. # 2007 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
resulted in the detection of a lesion. 3 Diffusionweighted (DWI) and diffusion tensor imaging (DTI) can detect white-matter-changes when conventional MRI findings are normal. 4, 5 EEG-correlated functional MRI yields blood-oxygen-level-dependent (BOLD) activation following epileptiform EEG-discharges that can be linked to the epileptic focus, even in patients without MRI abnormalities. 6 MR techniques like magnetic resonance spectroscopy (MRS) and methods that attempt to image neuronal electrical currents like the Lorentz effect imaging technique (LEI) are of experimental interest and might become clinically relevant in the future. 7 Typically, new diagnostic possibilities are tested in newly referred patients. Some patients who have been rejected for surgery might also benefit. One can imagine, however, that the disappointment of earlier rejection has led to acceptance of the situation and that these patients are reluctant to re-enter into another uncertain period. Disease burden may have decreased, either spontaneously or due to new treatment options like vagal nerve stimulation (VNS) and the advent of several new anti-epileptic drugs. 8 We wondered if patients who were once rejected are still motivated to undergo new diagnostic procedures which might re-open prospects of curative surgery.
Patients and methods
Patients were selected from the national database of the Dutch collaborative epilepsy surgery program (DCESP), which registers all patients considered for epilepsy surgery in the Netherlands since 1973. The selection was based on the following criteria: (1) rejection for epilepsy surgery between January 2001 and February 2006; (2) age older than 16 years; (3) IQ > 80; (4) no major psychiatric problems; (5) competent to fill in a Dutch questionnaire. Patients were approached by telephone, and were subsequently sent self-completion questionnaires. For respondents there was a chance of being offered new MR-related diagnostic procedures that recently became available in the Netherlands (3 T MRI and EEG-fMRI). Non-responders were re-contacted by phone and by sending another questionnaire to achieve maximum response. Missing data were derived from medical charts after written consent. Data were analyzed using the SPSSv12.0 statistical package (SPSS Inc., Chicago, USA).
Demographic and clinical characteristics
Data on current age, gender, marital status, employment, duration after rejection, age of disease onset and treatment were obtained. Age, sex and time since rejection of responders were compared to non-responders. Data were compared to Dutch epilepsy patients using one-sample t-tests for comparison of means and binomial tests for binomial data. Seizure frequency was estimated by the number of seizures per month, during the preceding month and during the past 2 years, and noting the time of the last seizure and the longest seizure-free period during the past 2 years. Frequencies were categorized as at least once a month, less often than once a month and not at all in the past year.
Motivation to undergo new diagnostic tests
The first question asked was whether the patient would be motivated to undergo novel diagnostic studies if these could possibly lead to reconsideration of surgery. This question was asked independently for the reason of rejection. Influence of time since rejection (independent sample t-test) and reason for rejection (x 2 -test) on motivation was studied.
Quality of life
Patients completed the SF-36: a non-disease-specific health status measure accessing eight different domains for which data on epilepsy patients and general population in the Netherlands are available. 9, 10 The scores of the general population, but not of the epilepsy population, were age-matched to the study-population. Scores of the rejected patients were compared to Dutch epilepsy patients using one-sample t-tests.
Results
Between January 2001 and February 2006, 441 patients (>16 years) were evaluated for surgery in the Netherlands by the DCESP. 37 patients were still in the work-up process at the cut-off date and 39 patients had withdrawn during evaluation. Of the 365 patients for whom a final decision was reached, 89 had been rejected (24%; 95% confidence interval 20-29%). Reasons for rejection were: no clear focus localization (47 patients), multi-focality (28 patients), seizures arising from a functionally eloquent area (12 patients) and coagulation disorders (2 patients). Of these 89, 18 patients were excluded from the study because of low IQ, psychiatric or language problems. Of the remaining 71 included patients, 64 (90%) completed questionnaires. Most of the non-responders agreed to fill in the questionnaires, but did not. 2 non-responders refused to participate after the first call. Charac-teristics of responders, non-responders and Dutch epilepsy patients are presented in Table 1 .
Motivation for new diagnostics
The motivation to undergo new diagnostic procedures is presented in Table 2 . The motivation was not influenced by the reason for rejection (Fisher's exact test two-sided p = 0.56) or the time after rejection ( p = 0.95). Of the highly motivated patients, localization problems (no clear focus or multi-focality) had been the main reason for rejection of surgery in 45 patients (70% of all patients). Of these, 9 patients had had a VNS implanted, which is a contra-indication for MRI. This means that for 36 out of 64 patients (56%; CI 43-69%) favorable conditions were met for re-evaluation by new MRItechniques.
Disease burden
Four patients (6%) did not have seizures during the last 6 months. Neither recent treatment (new medication or VNS) nor a demographic or disease characteristic could explain this improvement (two-tailed t-tests). Fig. 1 shows scores on eight SF-36-domains.
Discussion
Patients rejected as surgical candidates form a specific subgroup of patients with epilepsy. Compared to other patients with epilepsy, low scores on the vitality and social domains of quality of life were observed. Surprisingly, equal employment ratios and better scores on bodily pain and physical functioning were found. As the data of Dutch epilepsy patients were not corrected for age the actual difference on vitality and social domains, but also emotional and physical role limitations, may be even greater.
Most rejected patients are highly motivated to undergo novel diagnostic procedures that open prospects of surgery again. As the question was whether they were motivated for the diagnostic procedures in the first place and filling out the questionnaire could lead to novel MR diagnostics, the actual number of patients that are motivated for surgery might be lower. MRI techniques will not always be applicable, for instance because of VNS. Also, a selection should be made regarding which patients might profit from which techniques, based on the reason for rejection.
Few patients rejected for epilepsy surgery would no longer need surgery because of a low seizure frequency. A comparable number was found by others, 1 who reported that in a group of patients referred for epilepsy surgery 3% became seizure free after conservative treatment for 1 year. Apparently, even in long-standing refractory epilepsy spontaneous improvement is possible, at least within the scope of 1 year. It is likely that the motivation to undergo new procedures is not restricted to Dutch patients. In the Netherlands, most tests used worldwide are available like MRI (including high-resolution 3D T1 and FLAIR images), video-EEG, MEG, PET, ictal and interictal SPECT and invasive electrocorticography. The percentage of rejected patients is comparable with an American study. 2 Moreover, neither the reason of rejection for epilepsy surgery, nor the time lapse after rejection had an effect on the motivation of patients to undergo renewed evaluation.
Neurologists screening patients for epilepsy surgery should keep track of rejected patients and offer them new diagnostic techniques when these become available. Re-evaluation should be part of epilepsy surgery programs worldwide. Figure 1 Mean scale scores on the domains of the SF-36 for the study population compared with a group of Dutch patients with epilepsy and the general Dutch population. A higher score means a better score (so less pain, better functioning, etc.) on all domains. Significant differences between the study population and the Dutch patients with epilepsy are marked with an * ( p < 0.05; two-tailed one-sample t-test).
